 Acute Coronary Syndrome
"Acute Coronary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Descriptor ID |
D054058
|
| MeSH Number(s) |
C14.280.647.124 C14.907.585.124
|
| Concept/Terms |
Acute Coronary Syndrome- Acute Coronary Syndrome
- Acute Coronary Syndromes
- Coronary Syndrome, Acute
- Coronary Syndromes, Acute
- Syndrome, Acute Coronary
- Syndromes, Acute Coronary
|
Below are MeSH descriptors whose meaning is more general than "Acute Coronary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Acute Coronary Syndrome".
This graph shows the total number of publications written about "Acute Coronary Syndrome" by people in this website by year, and whether "Acute Coronary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 4 | 0 | 4 | | 2008 | 6 | 0 | 6 | | 2009 | 12 | 0 | 12 | | 2010 | 8 | 0 | 8 | | 2011 | 8 | 0 | 8 | | 2012 | 15 | 2 | 17 | | 2013 | 16 | 2 | 18 | | 2014 | 18 | 1 | 19 | | 2015 | 11 | 2 | 13 | | 2016 | 11 | 1 | 12 | | 2017 | 13 | 1 | 14 | | 2018 | 13 | 0 | 13 | | 2019 | 14 | 0 | 14 | | 2020 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Acute Coronary Syndrome" by people in Profiles.
-
Ray KK, Nicholls SJ, Buhr KA, Ginsberg HN, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Sweeney M, Schwartz GG. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2020 04 28; 323(16):1565-1573.
-
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Schwartz GG. Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. J Am Coll Cardiol. 2020 02 04; 75(4):448-451.
-
Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. J Am Coll Cardiol. 2020 01 21; 75(2):133-144.
-
Zijlstra LE, Schwartz GG, Steg PG, Jukema JW. Reply: Alirocumab in Polyvascular Atherosclerotic Disease. J Am Coll Cardiol. 2020 01 21; 75(2):241.
-
Salahuddin T, Kittelson J, Tardif JC, Shah PK, Olsson AG, Nicholls SJ, Leitersdorf E, Leiter LA, Kallend D, Black DM, Barter PJ, Ballantyne CM, Schwartz GG. Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial. Am Heart J. 2020 03; 221:60-66.
-
Schwartz GG, Chaitman BR. Initiating PCSK9 Inhibition in Hospital for ACS: We Can, But Does That Mean We Should? J Am Coll Cardiol. 2019 11 19; 74(20):2463-2465.
-
Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, Zeiher AM, Schwartz GG. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005858.
-
Amin AP, Spertus JA, Kulkarni H, McNeely C, Rao SV, Pinto D, House JA, Messenger JC, Bach RG, Goyal A, Shroff A, Pancholy S, Bradley SM, Gluckman TJ, Maddox TM, Wasfy JH, Masoudi FA. Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2020 02 01; 125(3):354-361.
-
Waksman R, Di Mario C, Torguson R, Ali ZA, Singh V, Skinner WH, Artis AK, Cate TT, Powers E, Kim C, Regar E, Wong SC, Lewis S, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Craig PE, Zou Q, Kolm P, Brewer HB, Garcia-Garcia HM. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. Lancet. 2019 11 02; 394(10209):1629-1637.
-
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, Ramos López GA, Roe MT, Viigimaa M, White HD, Zeiher AM, Steg PG, Schwartz GG. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. J Am Coll Cardiol. 2019 09 03; 74(9):1177-1186.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|